Sanofi, Yakult Honsha Link Arms on Zaltrap

February 7, 2017
Sanofi has picked Yakult Honsha as a copromotion partner in Japan for its colorectal cancer treatment aflibercept beta, known as Zaltrap overseas, which is expected to be approved as early as late March. The copromotion arrangement, the first such deal...read more